Company Filing History:
Years Active: 2000-2005
Title: The Innovative Contributions of Duncan Robert Hannah
Introduction
Duncan Robert Hannah is a prominent inventor based in Cambridge, GB. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that address various diseases. With a total of seven patents to his name, his work has the potential to impact the treatment of serious health conditions.
Latest Patents
Among his latest patents, Duncan has developed hydroxamic and carboxylic acid derivatives that are pharmacologically active. These compounds are designed for pharmaceutical compositions and methods aimed at treating cancer, inflammation, autoimmune diseases, infectious diseases, ocular diseases, and age-related macular degeneration in mammals. Additionally, he has created novel hydroxamic acid derivatives that serve as inhibitors of matrix metalloproteinase, ADAM, or ADAM-TS enzymes. These compounds are particularly useful for treating diseases mediated by these enzymes, including degenerative diseases and certain types of cancer.
Career Highlights
Duncan Robert Hannah is associated with Darwin Discovery Limited, where he continues to innovate and develop new therapeutic solutions. His work is characterized by a commitment to advancing medical science and improving patient outcomes through innovative drug development.
Collaborations
Duncan collaborates with notable colleagues, including Andrew Douglas Baxter and Hazel Joan Dyke, who contribute to his research and development efforts. Their combined expertise enhances the potential for groundbreaking discoveries in the pharmaceutical field.
Conclusion
Duncan Robert Hannah's contributions to pharmacology through his innovative patents and collaborations highlight his role as a key figure in the fight against serious diseases. His work continues to pave the way for new treatments that could significantly improve health outcomes for many individuals.